182 related articles for article (PubMed ID: 37112741)
1. Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1.
Klug G; Cole FM; Hicar MD; Watt C; Peters T; Pincus SH
Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112741
[TBL] [Abstract][Full Text] [Related]
2. Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.
Pincus SH; Song K; Maresh GA; Hamer DH; Dimitrov DS; Chen W; Zhang MY; Ghetie VF; Chan-Hui PY; Robinson JE; Vitetta ES
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852851
[TBL] [Abstract][Full Text] [Related]
3. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
[TBL] [Abstract][Full Text] [Related]
4. Anti-HIV double variable domain immunoglobulins binding both gp41 and gp120 for targeted delivery of immunoconjugates.
Craig RB; Summa CM; Corti M; Pincus SH
PLoS One; 2012; 7(10):e46778. PubMed ID: 23056448
[TBL] [Abstract][Full Text] [Related]
5. Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env.
Schapiro HM; Khasnis MD; Ahn K; Karagiaridi A; Hayden S; Cilento ME; Root MJ
PLoS Pathog; 2022 May; 18(5):e1010531. PubMed ID: 35584191
[TBL] [Abstract][Full Text] [Related]
6. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
Finnegan CM; Berg W; Lewis GK; DeVico AL
J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
[TBL] [Abstract][Full Text] [Related]
7. Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes.
Wang Q; Esnault F; Zhao M; Chiu TJ; Smith AB; Nguyen HT; Sodroski JG
J Virol; 2022 Apr; 96(7):e0187821. PubMed ID: 35289647
[TBL] [Abstract][Full Text] [Related]
8. Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.
Pincus SH; Song K; Maresh GA; Frank A; Worthylake D; Chung HK; Polacino P; Hamer DH; Coyne CP; Rosenblum MG; Marks JW; Chen G; Weiss D; Ghetie V; Vitetta ES; Robinson JE; Hu SL
J Virol; 2017 Feb; 91(3):. PubMed ID: 27795412
[TBL] [Abstract][Full Text] [Related]
9. Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6.
Verrier F; Nádas A; Gorny MK; Zolla-Pazner S
J Virol; 2001 Oct; 75(19):9177-86. PubMed ID: 11533181
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner.
Musich T; Li L; Liu L; Zolla-Pazner S; Robert-Guroff M; Gorny MK
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122974
[TBL] [Abstract][Full Text] [Related]
11. Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities.
Alsmadi O; Tilley SA
J Virol; 1998 Jan; 72(1):286-93. PubMed ID: 9420226
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW; Morrison O; Vassell R; Weiss CD
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
[TBL] [Abstract][Full Text] [Related]
13. Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded and -unliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virions.
Rathinakumar R; Dutta M; Zhu P; Johnson WE; Roux KH
J Virol; 2012 Feb; 86(3):1820-31. PubMed ID: 22090143
[TBL] [Abstract][Full Text] [Related]
14. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
Alsahafi N; Debbeche O; Sodroski J; Finzi A
PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
[TBL] [Abstract][Full Text] [Related]
15. Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity.
Pincus SH; Craig RB; Weachter L; LaBranche CC; Nabi R; Watt C; Raymond M; Peters T; Song K; Maresh GA; Montefiori DC; Kozlowski PA
Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358190
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.
Alam SM; Scearce RM; Parks RJ; Plonk K; Plonk SG; Sutherland LL; Gorny MK; Zolla-Pazner S; Vanleeuwen S; Moody MA; Xia SM; Montefiori DC; Tomaras GD; Weinhold KJ; Karim SA; Hicks CB; Liao HX; Robinson J; Shaw GM; Haynes BF
J Virol; 2008 Jan; 82(1):115-25. PubMed ID: 17942537
[TBL] [Abstract][Full Text] [Related]
17. Across Functional Boundaries: Making Nonneutralizing Antibodies To Neutralize HIV-1 and Mediate Fc-Mediated Effector Killing of Infected Cells.
Richard J; Nguyen DN; Tolbert WD; Gasser R; Ding S; Vézina D; Yu Gong S; Prévost J; Gendron-Lepage G; Medjahed H; Gottumukkala S; Finzi A; Pazgier M
mBio; 2021 Oct; 12(5):e0140521. PubMed ID: 34579568
[TBL] [Abstract][Full Text] [Related]
18. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies.
Broder CC; Earl PL; Long D; Abedon ST; Moss B; Doms RW
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11699-703. PubMed ID: 7972127
[TBL] [Abstract][Full Text] [Related]
19. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
20. Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers.
Yang Z; Dam KA; Gershoni JM; Zolla-Pazner S; Bjorkman PJ
J Virol; 2022 Dec; 96(24):e0108222. PubMed ID: 36448805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
